lower rebalanc estim
messag reduc estim slightli base guidanc
compani provid yesterday see press releas net sale increas
organ sale increas roughli share suffer among us
food peer year given rel weaker fundament high debt burden
remain neutral think compani offer lifelin pantri
stock higher consumpt confin long-term issu remain
intact chang ep estim
prev increas pt prev due higher
earn multipl
revis growth forecast lower consolid organ sale
growth prev maintain despit revis assumpt
foodservic steep declin repres roughli global sale
previous assum expect see tick-down tailwind pantri
stock think continu benefit higher rate at-hom
consumpt consum remain housebound across globe estim organ
sale
higher cost limit profit growth lower ep prev
model assum ebitda margin prev continu expect
 benefit oper leverag due higher volum unlik full impact
higher sale flow bottom line compani incur higher cost
meet increas demand priorit fewer sku gener larger pack size
come lower margin point model meaning reduct
advertis could expect gross margin benefit lower promot activ
new balanc sheet risk upsid earn year versu pre-coronaviru
expect provid margin benefit cash flow consid off-set roughli
higher interest expens due revolv draw-down still
model increas leverag ratio due y/
declin ebitda previous calcul stepped-up ebitda year
pantri stock higher consumpt provid roughli benefit compani
reiter dividend polici remain unchang net dont see increment
risk caution high debt burden recent downgrad junk statu
two rate agenc posit stock
postpon strateg review long-term challeng remain manag
increas market spend limit resourc behind weaken brand year
deep cost-cut investor spoken expect lot
compani upcom may investor day postpon later year
definit date announc visibl coronaviru impact
increas day-to-day stabil dont think investor read much
chang difficult becom construct stock meantim
opportun amid crisi recogn coronaviru outbreak take
signific person toll mani think could also provid ceo patricio rare
occas ralli organ around central purpos suppli food world
especi time extrem need mani brand remain challeng
view see evid recent survey conduct suggest consum
prefer brand privat label time uncertainti could translat
sustain increas household penetr brand
detail impact food coverag see coronaviru part food
benefit immun investor re-alloc
page analyst certif import disclosur
recent guggenheim secur consum research team perform proprietari
survey better understand shopper buy pattern recent stock-up
period survey suggest consum like trade-up
trust well-known brand rather trade valu brand privat label
figur recent survey suggest consum prefer purchas
trust well-known brand privat label valu option
page analyst certif import disclosur
consum survey resultsbuy pattern food brand bought valu bought trust well-known brand bought valu bought trust well-known food produc
valuat risk
prev price target base blend multipl forward
earn estim prev price-to-earnings ev ebitda multipl
repres discount valu given challeng
path organ sale growth price target increas result higher earn
valuat multipl due view less short-term risk compani
risk valuat
risk upsid
brand continu gain posit momentum focu brand build
compani gain posit momentum brand struggl
recent quarter trend revers powerhous brand lunchabl
kraft chees drive futur organ growth posit trend continu equat
larg portion compani sale
de-lever balanc sheet compani high debt-burden
coupl degrad ebitda base increas leverag ratio
time compani rapidli sell asset rais cash pay debt
would shore balanc sheet help lower borrow cost
risk downsid
privat label privat label alreadi neg impact mani compani
categori hold share half compani major categori
continu grow may continu pace faster expect allow privat
label rapidli take share compani mani categori
fail grow organ margin simultan compani
histori expand ebitda margin extrem low overhead cost
minim invest brand fail grow organ
compani may challeng maintain high ebitda margin also
organ grow busi brand build essenti like
lead declin ebitda dollar
page analyst certif import disclosur
page analyst certif import disclosur
incom million except per erecastrecastrecastmar y-o-i growth cost good gross gross sell gener expens total oper sg oper oper y-o-i growth ebitda y-o-i growth net interest incom incom tax non-control incom adj dilut y-o-i growth dilut share sale breakdownpricena volum mixna acquisit divestitur na currencyna extra week otherna net sale growthna organ growthna food produc
issu research report guggenheim secur llc guggenheim secur research analyst whose name appear report
herebi certifi view express report accur reflect research analyst person view subject
secur issuer discuss herein ii part research analyst compens directli indirectli relat specif
recommend view express research analyst
research analyst whose name appear report receiv compens base upon variou factor includ qualiti research
investor client feedback guggenheim secur llc overal revenu includ invest bank revenu
guggenheim secur llc affili expect receiv intend seek compens invest bank servic
compani next month
pleas refer websit company-specif disclosur referenc report http //guggenheimsecur bluematrix com/sellside/
disclosur action disclosur inform also avail complianc madison avenu new york ny
rate price target histori kraft heinz compani
creat bluematrix
buy describ stock expect provid total return price appreci plu yield within period
neutral describ stock expect provid total return price appreci plu yield plu minu within
sell describ stock expect provid total neg return price appreci plu yield within period
nr invest rate price target temporarili suspend suspens complianc applic regul and/or
cs coverag suspend guggenheim secur llc suspend coverag compani
nc cover guggenheim secur llc cover compani
monitor describ stock whose compani fundament financi monitor financi project opinion
invest merit compani provid
review ur follow releas signific news compani rate temporarili place review suffici
inform obtain assess analyst
guggenheim secur llc methodolog assign rate may includ follow market capit matur growth/valu volatil
expect total return next month price target base sever methodolog may includ restrict analys
market risk growth rate revenu stream discount cash flow dcf ebitda ep cash flow cf free cash flow ev/ebitda price-to-earnings pe/growth
price-to-cf p/fcf premium discount /averag group ev/ebitda premium discount /averag group price-to-earnings sum part net asset valu dividend return
return equiti roe next month
price target assign buy- sell-rat stock price target neutral-r stock provid discret analyst
page analyst certif import disclosur
